
IndraLab
Statements
reach
"To verify whether this shRNA effect is dependent on inhibition of the deubiquitinating activity of USP14, we used IU1, a potent pharmacological inhibitor that selectively inhibits USP14 by preventing its docking on the proteasome [XREF_BIBR], and tested the effect of USP14 inhibition by IU1 on the AR expression in breast cancer cells."